Alector, Inc. Increase (Decrease) in Accounts Receivable
Alector, Inc. (ALEC) reported Increase (Decrease) in Accounts Receivable of -$238.00 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Cash Flow
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2019-11-12
- Alector, Inc. increase (decrease) in accounts receivable for the quarter ending 2018-09-30 was $0.00.
- Alector, Inc. increase (decrease) in accounts receivable for the quarter ending 2018-06-30 was -$169.00K.
- Alector, Inc. increase (decrease) in accounts receivable for the quarter ending 2018-03-31 was -$69.00K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month |
|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$169.00K derived: sum of 2 quarters · filed 2019-11-12 | -$238.00K 10-Q · filed 2019-11-12 |
| 2018-06-30 | -$169.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$238.00K 10-Q · filed 2019-08-12 | |
| 2018-03-31 | -$69.00K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |